Skip to main content
CBT
NYSE Industrial Applications And Services

Cabot Corporation CEO Sean Keohane to Retire; CFO Erica McLaughlin Named Successor

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Chemical Stocks · Materials
Sentiment info
Neutral
Importance info
7
Price
$91.43
Mkt Cap
$4.725B
52W Low
$58.33
52W High
$94.53
52W Position info
57% above low
Off High info
3.3% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

CBT sits 57% above its 52-week low of $58.33.

Summary

Cabot Corporation CEO Sean Keohane will retire on September 30, 2026, and be succeeded by CFO Erica McLaughlin on October 1, 2026. The transition includes an advisory role for Keohane through year-end and a CFO search.


Key Events · Executive and Board Changes · CBT

  • CEO Retirement and Succession

    President and CEO Sean Keohane will retire effective September 30, 2026, and resign from the board. Erica McLaughlin, currently EVP and CFO, will become President and CEO and join the board on October 1, 2026.

  • Compensation for Incoming CEO

    McLaughlin's base salary increases to $910,000 per year, and her target short-term incentive bonus rises to 120% of base salary, effective October 1, 2026.

  • Transition Agreement for Outgoing CEO

    Keohane will remain as a non-executive employee through December 31, 2026, to assist with the transition. His outstanding equity awards will receive retirement vesting treatment, and he will receive financial planning benefits for 24 months post-retirement.

  • CFO Search Initiated

    The company has commenced a search process to identify a new Chief Financial Officer following McLaughlin's promotion.


Analysis · CBT · Industrial Applications And Services

A planned CEO transition is underway at Cabot Corporation. Sean Keohane will retire as President and CEO and step down from the board effective September 30, 2026. Succeeding him on October 1, 2026, is Erica McLaughlin, currently Executive Vice President and CFO, who will also join the board. The handover appears orderly, with Keohane staying on as an advisor through year-end. McLaughlin's base salary rises to $910,000 and her target short-term incentive increases to 120% of base. A search for a new CFO is now in progress. While any CEO change carries execution risk, promoting a 25-year veteran internally suggests continuity, and the market is likely to view this as a neutral-to-slightly-positive succession plan.

At the time of this filing, CBT was trading at $91.43 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $4.7B. The 52-week trading range was $58.33 to $94.53. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CBT - Latest Insights

CBT
May 14, 2026, 8:00 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $82.90
Real-time Price: $91.50 info
Change: +$8.60 (+10%) info
Market Cap: $4.725B info
CBT
May 06, 2026, 4:23 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $82.41
Real-time Price: $91.50 info
Change: +$9.09 (+11%) info
Market Cap: $4.725B info
CBT
May 05, 2026, 5:01 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $79.66
Real-time Price: $91.50 info
Change: +$11.84 (+15%) info
Market Cap: $4.725B info
CBT
May 05, 2026, 4:30 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $78.93
Real-time Price: $91.50 info
Change: +$12.57 (+16%) info
Market Cap: $4.725B info
CBT
May 04, 2026, 7:16 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $75.85
Real-time Price: $91.50 info
Change: +$15.65 (+21%) info
Market Cap: $4.725B info